KCNMA1 and fragile X syndrome: It was recently shown that calcium chelation with BAPTA prevented the BK channel-mediated excessive neurotransmitter release that is seen in the CA pyramidal neurons of a mouse model with fragile X syndrome, and that this is secondary to disease-mediated impairment of BK channel sensitivity to calcium [41].